A multicenter randomized phase III study of paclitaxel (175 mg/m (2)) plus carboplatin (AUC 6) versus paclitaxel (225 mg/m (2)) plus carboplatin (AUC 6) in advanced non-small cell lung cancer (NSCLC)

Authors: DV Skarlos Mylonakis, N Fountzilas, G Samantas, E Dimopoulos, MA Papadimitriou, C Kalofonos, H Pavlidis, N Papakonstantinou, C Kosmidis, P
Publication date: 1 January 1999
Publisher

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens

redirect

oai

oai:lib.uoa.gr:uoadl:2954002

Last time updated on 10/02/2023